X @The Economist

Pharmaceutical Industry Policy & Investment - Europe could stimulate R&D investment in lifesaving drugs by increasing reimbursements for new drugs [1] - Increased use of cheaper generic therapies is suggested as a cost-saving measure [1] - The policy aims to counter Donald Trump's pricing push, which is considered mutually destructive [1]